Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ·Healthcare·Biotechnology
$16.17
+5.14%
Mkt Cap $1.92B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+116.5%
Consensus $35.00 vs current $16.17
NASDAQ·Healthcare·Biotechnology
$16.17
+5.14%
Mkt Cap $1.92B
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
+116.5%
Consensus $35.00 vs current $16.17